GPR35 and familial pancreatic carcinoma: The expression of GPR35 is significantly elevated in PDAC tumor tissues, and its expression level shows a positive correlation trend with tumor stage, grade, and resectability, suggesting it may represent a potential biomarker for pancreatic cancer.